Author:
Amblard Franck,Boucle Sebastien,Bassit Leda,Chen Zhe,Sari Ozkan,Cox Bryan,Verma Kiran,Ozturk Tugba,Ollinger-Russell Olivia,Schinazi Raymond F.
Funder
Center for AIDS Research, Emory University
National Institutes of Health
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference14 articles.
1. World Health Organization (WHO) website, available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 02 June 2020.
2. Recent advances in the development of HBV capsid assembly modulators;Nijampatnam;Curr Opin Chem Biol,2019
3. Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379 Antimicrob;Berke;Agents Chemother,2020
4. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial;Yuen;Lancet Gastroenterol Hepatol,2020
5. Yuen MF, Agarwal K, Gane EJ, et al. The second-generation hepatitis B virus (HBV) core inhibitor (CI) ABI-H2158 is associated with potent antiviral activity in a 14-Day monotherapy study in HBeAg-positive patients with chronic hepatitis B (CHB) AASLD 2019 Nov 8-12 Boston.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献